Interim Analysis of a Phase 2 Open‐Label Trial Assessing Burosumab Efficacy and Safety in Patients With Tumor‐Induced Osteomalacia

Patients with tumor‐induced osteomalacia (TIO), an acquired paraneoplastic condition characterized by osteomalacia due to hypophosphatemia, exhibit a similar clinical picture to those with X‐linked hypophosphatemic rickets/osteomalacia (XLH). The human monoclonal anti‐fibroblast growth factor 23 (FG...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:J Bone Miner Res
Main Authors: Imanishi, Yasuo, Ito, Nobuaki, Rhee, Yumie, Takeuchi, Yasuhiro, Shin, Chan Soo, Takahashi, Yutaka, Onuma, Hiroki, Kojima, Masahiro, Kanematsu, Masanori, Kanda, Hironori, Seino, Yoshiki, Fukumoto, Seiji
Format: Artigo
Sprog:Inglês
Udgivet: John Wiley & Sons, Inc. 2020
Fag:
Clinical Trial
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7988547/
https://ncbi.nlm.nih.gov/pubmed/32967046
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jbmr.4184
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker